FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM

Jacques De Greve; J Van Meerbeek; J. Vansteenkiste; Erik Teugels; Caroline Geers; Ap Meert; Peter Vuylsteke; C. Focan; J-L Canon; Y. Humblet; G. Berchem; Benoit Colinet; D. Galdermans; L Bosquée; Christophe Dooms; Lore Decoster; Joanna Vermeij; Alex Dewaele; Denis Schallier

FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM

Jacques De Greve, J Van Meerbeek, J. Vansteenkiste, Erik Teugels, Caroline Geers, Ap Meert, Peter Vuylsteke, C. Focan, J-L Canon, Y. Humblet, G. Berchem, Benoit Colinet, D. Galdermans, L Bosquée, Christophe Dooms, Lore Decoster, Joanna Vermeij, Alex Dewaele, Denis Schallier

Pathologische Anatomie

Onderzoeksoutput: Editorial

Samenvatting

No abstract available

Originele taal-2	English
Pagina's (van-tot)	1270-1270
Aantal pagina's	1
Tijdschrift	Journal of Thoracic Oncology
Volume	6
Nummer van het tijdschrift	6
Status	Published - jun. 2011

Toegang tot document

http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=P2gANJ1LMG2bPhM1oaE&page=1&doc=1

Citeer dit

De Greve, J., Van Meerbeek, J., Vansteenkiste, J., Teugels, E., Geers, C., Meert, A., Vuylsteke, P., Focan, C., Canon, J.-L., Humblet, Y., Berchem, G., Colinet, B., Galdermans, D., Bosquée, L., Dooms, C., Decoster, L., Vermeij, J., Dewaele, A., & Schallier, D. (2011). FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM. Journal of Thoracic Oncology, 6(6), 1270-1270. http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=P2gANJ1LMG2bPhM1oaE&page=1&doc=1

@article{c562ff860680452a8906e3bcfc611e22,

title = "FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM",

abstract = "No abstract available",

keywords = "ERLOTINIB, NON-SMALL LUNG CANCER, EGFR MUTATION, PHASE II",

author = "{De Greve}, Jacques and {Van Meerbeek}, J and J. Vansteenkiste and Erik Teugels and Caroline Geers and Ap Meert and Peter Vuylsteke and C. Focan and J-L Canon and Y. Humblet and G. Berchem and Benoit Colinet and D. Galdermans and L Bosqu{\'e}e and Christophe Dooms and Lore Decoster and Joanna Vermeij and Alex Dewaele and Denis Schallier",

year = "2011",

month = jun,

language = "English",

volume = "6",

pages = "1270--1270",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "6",

}

De Greve, J, Van Meerbeek, J, Vansteenkiste, J, Teugels, E, Geers, C, Meert, A, Vuylsteke, P, Focan, C, Canon, J-L, Humblet, Y, Berchem, G, Colinet, B, Galdermans, D, Bosquée, L, Dooms, C, Decoster, L, Vermeij, J, Dewaele, A & Schallier, D 2011, 'FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM', Journal of Thoracic Oncology, vol. 6, nr. 6, blz. 1270-1270. <http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=P2gANJ1LMG2bPhM1oaE&page=1&doc=1>

TY - JOUR

T1 - FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM

AU - De Greve, Jacques

AU - Van Meerbeek, J

AU - Vansteenkiste, J.

AU - Teugels, Erik

AU - Geers, Caroline

AU - Meert, Ap

AU - Vuylsteke, Peter

AU - Focan, C.

AU - Canon, J-L

AU - Humblet, Y.

AU - Berchem, G.

AU - Colinet, Benoit

AU - Galdermans, D.

AU - Bosquée, L

AU - Dooms, Christophe

AU - Decoster, Lore

AU - Vermeij, Joanna

AU - Dewaele, Alex

AU - Schallier, Denis

PY - 2011/6

Y1 - 2011/6

N2 - No abstract available

AB - No abstract available

KW - ERLOTINIB

KW - NON-SMALL LUNG CANCER

KW - EGFR MUTATION

KW - PHASE II

M3 - Editorial

SN - 1556-0864

VL - 6

SP - 1270

EP - 1270

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 6

ER -

FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit